Inflammopharmacology
Cure8 research brief
Why This Matters
TRPV channels are proposed as integrative mediators of inflammation, angiogenesis, and oxidative stress in IBD, suggesting new mechanistic targets that could eventually yield novel therapies for Crohn's disease and ulcerative colitis.
Who Should Pay Attention
Researchers, translational scientists, drug developers, and clinicians interested in emerging IBD mechanisms and potential therapeutic targets.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a peer-reviewed review article (abstract provided) summarizing preclinical and mechanistic evidence about TRPV family members (TRPV1–6) in intestinal cells, immune cells, sensory neurons, and endothelium.
The authors outline how TRPV-mediated calcium and reactive oxygen species signaling could create a feed-forward network linking inflammation, angiogenesis, and oxidative stress in IBD, and they discuss experimental therapeutic approaches including small-molecule modulators, natural compounds, combination strategies, and tissue-directed delivery.
The review is focused on mechanistic and translational science rather than clinical trial results. It highlights opportunities and significant pharmacological challenges in moving TRPV modulation toward clinical use.
Keep In Mind
This is a narrative/review article summarizing preclinical and mechanistic studies (abstract-level content). It does not provide clinical trial evidence; the translational path to safe, effective TRPV-targeted therapies remains uncertain.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInflammopharmacology
AuthorsPeihong Li, Yikun Zhang, Siqing Guo +7 more
InstitutionDepartment of Gastroenterology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Study typeJournal article, review
Indexed viaPubMed
Source typeResearch paper
PublishedJul 27, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: Not applicable. Consent for publication: All authors consent to the publication of this manuscript.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease.
This review spotlights non-bacterial members of the gut microbiota (viruses and fungi) that may contribute to IBD by altering barrier function, immune responses, and interactions with bacteria. For people with IBD, these...
Crosstalk between circRNAs and the classic signaling pathways in IBD.
Researchers are exploring circRNAs as new molecular players in IBD inflammation; that could lead to future biomarker tests or novel treatments targeting immune pathways relevant to Crohn’s disease and ulcerative colitis.
Artificial Intelligence in the Nutritional Management of Inflammatory Bowel Disease: A Scoping Review.
AI could help identify dietary patterns, predict which patients might benefit from specific nutrition approaches, and provide personalized nutrition support — potentially improving inflammation and gut microbiome...